Human Phosphoglycerate Dehydrogenase Produces the Oncometabolite d-2-Hydroxyglutarate
Human d-3-phosphoglycerate dehydrogenase (PHGDH), the first enzyme in the serine biosynthetic pathway, is genomically amplified in tumors including breast cancer and melanoma. In PHGDH-amplified cancer cells, knockdown of PHGDH is not fully rescued by exogenous serine, suggesting possible additional...
Main Authors: | Teng, Xin (Author), Liu, Ling (Author), Looper, Ryan E. (Author), Rabinowitz, Joshua D. (Author), Vander Heiden, Matthew G. (Contributor), Mattaini, Katherine Ruth (Contributor), Fan, Jing,M. Eng.Massachusetts Institute of Technology (Author) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor) |
Format: | Article |
Language: | English |
Published: |
American Chemical Society (ACS),
2016-12-15T14:42:06Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
The role of phosphoglycerate dehydrogenase in cell proliferation and tumor progression
by: Mattaini, Katherine R. (Katherine Ruth)
Published: (2016) -
Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous Metabolite
by: Raffaela S. Berger, et al.
Published: (2021-04-01) -
Potent immunosuppressive effects of the oncometabolite R-2-hydroxyglutarate
by: Lorenzo Galluzzi, et al.
Published: (2018-12-01) -
The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway
by: Mélissa Carbonneau, et al.
Published: (2016-09-01) -
The Enzymology of 2-Hydroxyglutarate, 2-Hydroxyglutaramate and 2-Hydroxysuccinamate and Their Relationship to Oncometabolites
by: Vivek A. Hariharan, et al.
Published: (2017-03-01)